Cormac Devlin (Dún Laoghaire, Fianna Fail)
Link to this: Individually | In context | Oireachtas source

I am chair of the all-party Oireachtas committee on diabetes. I am aware of a framework being discussed by the HSE and providers of certain continuous glucose monitors, CGM. It is taking a long time. There was a previous attempt in 2017 and 2018 to get approval for a particular monitor.

That has an impact on those with diabetes. I do not expect Ms O'Connor to have the information right now but if she could come back to me on that, we need to have a definitive timeframe, given the fact that it is at least four years in discussions with the HSE, and also on the LTI list. The supports and adaptations for the CGM monitors also need to be included on the LTI list.

As I am conscious of time I will turn to the value for money aspect for nursing homes. In the documentation it states the cost of providing service in a public nursing home was two-and-a-half times the cost in a public nursing home. What is the update now that report has been published? What will we see in changes of the funding model? What is the thinking within the HSE on the Value for Money report?